Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of intravitreal dexamethasone posterior segment drug delivery system for diabetic macular edema
2004-004997-10Phase 3Completed
- Sponsor
- Allergan
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in diabetic macular edema (DME) (3 arms), sponsored by Allergan. Primary endpoint: Best corrected visual acuity average change from baseline during the study. Started Apr 2006; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2004-004997-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004997-10.